Ftse Mib
33.294,96
0,20%
DAX
19.146,17
0,76%
S&P 500
5.948,71
0,53%
NASDAQ
18.972,42
0,03%
Bitcoin
98.302,61
-0,21%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Virpax Pharmaceuticals Inc (VRPX) Virpax Pharmaceuticals Inc (VRPX) Notizie

Virpax Pharmaceuticals Inc

VRPX
1,0998
0,4828 (78,25%)
22 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202422:05BWVirpax Announces Agreement with the U.S. Department of..
20/11/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
20/11/202412:06EDGAR2Form 8-K - Current report
18/11/202416:23GLOBESpartan Capital Securities, LLC Serves as Sole Placement..
15/11/202423:20EDGAR2Form 8-K - Current report
15/11/202422:09BWVirpax Pharmaceuticals, Inc. Announces Closing of $5.0..
14/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202423:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
13/11/202415:15BWVirpax Pharmaceuticals, Inc. Announces Pricing of $5.0..
13/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/11/202423:01EDGAR2Form S-1/A - General form for registration of securities..
05/11/202414:30GLOBEAdial Pharmaceuticals Appoints Vinay Shah as Chief Financial..
28/10/202421:08EDGAR2Form S-1/A - General form for registration of securities..
18/10/202423:28EDGAR2Form S-1/A - General form for registration of securities..
10/10/202423:08EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
10/10/202423:07EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
09/10/202423:00EDGAR2Form 8-K/A - Current report: [Amend]
04/10/202422:30EDGAR2Form 8-K - Current report
03/10/202422:45EDGAR2Form 8-K - Current report
03/10/202422:30EDGAR2Form 8-K - Current report
25/9/202422:12EDGAR2Form 8-K - Current report
17/9/202422:11EDGAR2Form 8-K - Current report
13/8/202415:05EDGAR2Form S-1/A - General form for registration of securities..
13/8/202413:35EDGAR2Form 8-K - Current report
13/8/202413:30BWVirpax Pharmaceuticals Reports 2024 Second Quarter Results..
12/8/202422:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:30BWVirpax Pharmaceuticals to Present at Sidoti Virtual Investor..
30/7/202423:26EDGAR2Form 8-K - Current report
29/7/202422:30EDGAR2Form S-1 - General form for registration of securities under..
26/7/202422:31EDGAR2Form 8-K - Current report
24/7/202413:45EDGAR2Form 8-K - Current report
24/7/202413:30BWVirpax Regains Compliance with Nasdaq Minimum Bid Price
16/7/202400:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/7/202414:00EDGAR2Form 8-K - Current report
10/7/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202422:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/7/202418:48EDGAR2Form 8-K - Current report
10/7/202413:30BWVirpax Announces Positive Results of Swine Model Pilot Study..
09/7/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202422:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/7/202422:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/7/202413:30EDGAR2Form 8-K - Current report
08/7/202413:30BWVirpax Pharmaceuticals Secures $2.5 Million Loan Financing..
12/6/202423:09EDGAR2Form DEF 14A - Other definitive proxy statements
29/5/202413:30BWVirpax® Pharmaceuticals to Present at 2024 BIO International..
17/5/202422:05EDGAR2Form 8-K - Current report
16/5/202422:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
15/5/202414:00BWVirpax Announces Pricing of $2.25 Million Public Offering
13/5/202423:30EDGAR2Form S-1/A - General form for registration of securities..
13/5/202422:20EDGAR2Form 8-K - Current report
Apertura: 0,5985 Min: 0,5822 Max: 0,72
Chiusura: 0,617

La tua Cronologia

NASDAQ
VRPX
Virpax Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network